FTC Accuses Hims & Hers of Sharing User Health Data With Meta, Snap

WHO:

CBS News - The Federal Trade Commission (FTC) is involved in the lawsuit against Hims & Hers.

Inc - Hims & Hers is identified as a telehealth platform.

WHAT:

NY Post - Hims & Hers stock was trading down around 12% following the news of the FTC lawsuit.

CBS News - The FTC alleges that Hims & Hers shared users' "most private" health information with Meta and Snap.

Inc - The FTC claims that Hims & Hers charged customers before consultations and made subscriptions difficult to cancel.

WHERE:

CBS News - The allegations pertain to the operations of Hims & Hers, which is a telehealth platform.

WHY:

Inc - The FTC's lawsuit suggests that Hims & Hers misled users regarding their privacy and the handling of sensitive health data.

HOW:

CBS News - The FTC claims that Hims & Hers disclosed sensitive user health information to advertising platforms.

(UPDATED July 29, 2026 23:19 UTC)

Hims & Hers stock took a hit today, trading down around twelve percent after the announcement of a lawsuit from the FTC. The news has raised concerns among investors, prompting a significant drop in the company's shares. As the situation develops, all eyes will be on how Hims & Hers responds to the legal challenges ahead.

--

(UPDATED July 29, 2026 22:28 UTC)

The Federal Trade Commission is taking legal action against Hims & Hers, a telehealth platform, over serious allegations regarding user privacy. The FTC claims that Hims & Hers shared users' most private health information with Meta and Snap, charged customers before consultations, and made it difficult to cancel subscriptions. According to the lawsuit, these practices misled users about how their sensitive health data was handled.